We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron Secures HHS Funding for MERS Therapy
Regeneron has inked an agreement with HHS to manufacture and study two antibody therapies for the prevention and treatment of Middle East Respiratory Syndrome.